MENU
CYTK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cytokinetics (CYTK) Ownership - Who owns Cytokinetics?
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
350 Oyster Point Boulevard
Phone
+1 650 624-3000
Employees
564
Web
https://www.cytokinetics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.82B
P/E Ratio
N/A
Total Cash
1.08B
Projected Growth
N/A
Total Debt
788.68M
Revenue
18.47M
Risk (Beta)
0.35
Dividend Yield
N/A
Total Cash/Share
9.03
Total Debt/Equity
N/A
Revenue/Share
0.17 USD as % of share price
Fundamentals
CYTK
Capitalization
4.82B
P/E Ratio
N/A
Risk (Beta)
0.35
Dividend Yield
N/A
Total Cash
1.08B
Total Cash/Share
9.03
Total Debt
789M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.17%
Revenue
18.5M
ROE
N/A
Book Value
-135.37M
P/B Ratio
60.61
Cash Flow
N/A
Earnings
-5.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
118K
Current Ratio
6.17
Current Revenue Per Employee
33989.96
Dividends Per Share - Security
N/A
EBITDA
-493.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
-453.13
Revenue To Assets
-52.97
Shares Held By Institutions
12.5B
Shares Outstanding - Current
119M
Total Liabilities
1.54B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-14.052
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in discovery and development of small molecule drug therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
350 Oyster Point Boulevard
Phone
+1 650 624-3000
Employees
564
Web
https://www.cytokinetics.com